Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
Saved in:
| Title: | Sialyl-Tn serves as a potential therapeutic target for ovarian cancer. |
|---|---|
| Authors: | Al-Alem L; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA., Prendergast JM; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Clark J; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Zarrella B; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Zarrella DT; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Hill SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Growdon WB; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Pooladanda V; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA., Spriggs DR; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Cramer D; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, 02115, USA., Elias KM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Nazer RI; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Skates SJ; Biostatistics Center, Massachusetts General Hospital, Boston, MA, 02114, USA., Behrens J; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Dransfield DT; Siamab Therapeutics, Inc, Newton, MA, 02458, USA., Rueda BR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA. brueda@mgh.harvard.edu.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu. |
| Source: | Journal of ovarian research [J Ovarian Res] 2024 Apr 02; Vol. 17 (1), pp. 71. Date of Electronic Publication: 2024 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101474849 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-2215 (Electronic) Linking ISSN: 17572215 NLM ISO Abbreviation: J Ovarian Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38566237 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sialyl-Tn serves as a potential therapeutic target for ovarian cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Al-Alem+L%22">Al-Alem L</searchLink>; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Prendergast+JM%22">Prendergast JM</searchLink>; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.<br /><searchLink fieldCode="AU" term="%22Clark+J%22">Clark J</searchLink>; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.<br /><searchLink fieldCode="AU" term="%22Zarrella+B%22">Zarrella B</searchLink>; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.<br /><searchLink fieldCode="AU" term="%22Zarrella+DT%22">Zarrella DT</searchLink>; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.<br /><searchLink fieldCode="AU" term="%22Hill+SJ%22">Hill SJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Growdon+WB%22">Growdon WB</searchLink>; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.<br /><searchLink fieldCode="AU" term="%22Pooladanda+V%22">Pooladanda V</searchLink>; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Spriggs+DR%22">Spriggs DR</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.<br /><searchLink fieldCode="AU" term="%22Cramer+D%22">Cramer D</searchLink>; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Elias+KM%22">Elias KM</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Nazer+RI%22">Nazer RI</searchLink>; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.<br /><searchLink fieldCode="AU" term="%22Skates+SJ%22">Skates SJ</searchLink>; Biostatistics Center, Massachusetts General Hospital, Boston, MA, 02114, USA.<br /><searchLink fieldCode="AU" term="%22Behrens+J%22">Behrens J</searchLink>; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.<br /><searchLink fieldCode="AU" term="%22Dransfield+DT%22">Dransfield DT</searchLink>; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.<br /><searchLink fieldCode="AU" term="%22Rueda+BR%22">Rueda BR</searchLink>; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA. brueda@mgh.harvard.edu.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101474849%22">Journal of ovarian research</searchLink> [J Ovarian Res] 2024 Apr 02; Vol. 17 (1), pp. 71. <i>Date of Electronic Publication: </i>2024 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101474849 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-2215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217572215%22">17572215 </searchLink><i>NLM ISO Abbreviation: </i>J Ovarian Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38566237 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13048-024-01397-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 71 Titles: – TitleFull: Sialyl-Tn serves as a potential therapeutic target for ovarian cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Al-Alem L – PersonEntity: Name: NameFull: Prendergast JM – PersonEntity: Name: NameFull: Clark J – PersonEntity: Name: NameFull: Zarrella B – PersonEntity: Name: NameFull: Zarrella DT – PersonEntity: Name: NameFull: Hill SJ – PersonEntity: Name: NameFull: Growdon WB – PersonEntity: Name: NameFull: Pooladanda V – PersonEntity: Name: NameFull: Spriggs DR – PersonEntity: Name: NameFull: Cramer D – PersonEntity: Name: NameFull: Elias KM – PersonEntity: Name: NameFull: Nazer RI – PersonEntity: Name: NameFull: Skates SJ – PersonEntity: Name: NameFull: Behrens J – PersonEntity: Name: NameFull: Dransfield DT – PersonEntity: Name: NameFull: Rueda BR IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 04 Text: 2024 Apr 02 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1757-2215 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Journal of ovarian research Type: main |
| ResultId | 1 |